Alpine Immune Sciences Stock Shares Outstanding
| ALPN Stock | USD 64.96 0.01 0.02% |
Alpine Immune Sciences fundamentals help investors to digest information that contributes to Alpine Immune's financial success or failures. It also enables traders to predict the movement of Alpine Stock. The fundamental analysis module provides a way to measure Alpine Immune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpine Immune stock.
As of the 16th of May 2024, Common Stock Shares Outstanding is likely to grow to about 52.5 M. Alpine | Shares Outstanding |
Alpine Immune Sciences Company Shares Outstanding Analysis
Alpine Immune's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Alpine Immune Shares Outstanding | 68.6 M |
Most of Alpine Immune's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpine Immune Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Alpine Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Alpine Immune is extremely important. It helps to project a fair market value of Alpine Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Alpine Immune's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alpine Immune's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alpine Immune's interrelated accounts and indicators.
Click cells to compare fundamentals
Alpine Shares Outstanding Historical Pattern
Today, most investors in Alpine Immune Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alpine Immune's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Alpine Immune shares outstanding as a starting point in their analysis.
Alpine Immune Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Alpine Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Alpine Immune Sciences has 68.6 M of shares currently outstending. This is 62.0% lower than that of the Biotechnology sector and 35.8% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 88.0% higher than that of the company.
Alpine Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpine Immune's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics of similar companies.Alpine Immune is currently under evaluation in shares outstanding category among related companies.
Alpine Immune Current Valuation Drivers
We derive many important indicators used in calculating different scores of Alpine Immune from analyzing Alpine Immune's financial statements. These drivers represent accounts that assess Alpine Immune's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Alpine Immune's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 70.5M | 262.4M | 352.9M | 953.0M | 857.7M | 900.6M | |
| Enterprise Value | 70.7M | 250.1M | 304.6M | 919.0M | 827.1M | 868.5M |
Alpine Immune ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alpine Immune's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alpine Immune's managers, analysts, and investors.Environmental | Governance | Social |
Alpine Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (3.23) % | ||||
| Current Valuation | 4.16 B | ||||
| Shares Outstanding | 68.6 M | ||||
| Shares Owned By Insiders | 4.60 % | ||||
| Shares Owned By Institutions | 98.90 % | ||||
| Number Of Shares Shorted | 3.89 M | ||||
| Price To Earning | (32.69) X | ||||
| Price To Book | 12.87 X | ||||
| Price To Sales | 71.68 X | ||||
| Revenue | 58.88 M | ||||
| Gross Profit | (40.18 M) | ||||
| EBITDA | (43.67 M) | ||||
| Net Income | (32.18 M) | ||||
| Cash And Equivalents | 167.86 M | ||||
| Cash Per Share | 5.52 X | ||||
| Total Debt | 9.91 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 5.08 X | ||||
| Cash Flow From Operations | (79.01 M) | ||||
| Short Ratio | 0.96 X | ||||
| Earnings Per Share | (0.64) X | ||||
| Target Price | 62.0 | ||||
| Number Of Employees | 142 | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 4.46 B | ||||
| Total Asset | 381.81 M | ||||
| Retained Earnings | (256.14 M) | ||||
| Working Capital | 288.05 M | ||||
| Current Asset | 25.53 M | ||||
| Current Liabilities | 3.39 M | ||||
| Net Asset | 381.81 M |
About Alpine Immune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpine Immune Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Alpine Immune Investors Sentiment
The influence of Alpine Immune's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Alpine. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Alpine Immune's public news can be used to forecast risks associated with an investment in Alpine. The trend in average sentiment can be used to explain how an investor holding Alpine can time the market purely based on public headlines and social activities around Alpine Immune Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Alpine Immune's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Alpine Immune's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Alpine Immune's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Alpine Immune.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alpine Immune in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alpine Immune's short interest history, or implied volatility extrapolated from Alpine Immune options trading.
Check out Alpine Immune Piotroski F Score and Alpine Immune Altman Z Score analysis. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Alpine Stock analysis
When running Alpine Immune's price analysis, check to measure Alpine Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpine Immune is operating at the current time. Most of Alpine Immune's value examination focuses on studying past and present price action to predict the probability of Alpine Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpine Immune's price. Additionally, you may evaluate how the addition of Alpine Immune to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Alpine Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alpine Immune. If investors know Alpine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alpine Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 1.044 | Quarterly Revenue Growth (0.25) | Return On Assets (0.10) | Return On Equity (0.15) |
The market value of Alpine Immune Sciences is measured differently than its book value, which is the value of Alpine that is recorded on the company's balance sheet. Investors also form their own opinion of Alpine Immune's value that differs from its market value or its book value, called intrinsic value, which is Alpine Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alpine Immune's market value can be influenced by many factors that don't directly affect Alpine Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alpine Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alpine Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alpine Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.